You are about to leave this website for another external website. Gamida Cell has no responsibility for the content of such other sites and is not liable for any damages or injury arising from that content. Any links to other sites are provided merely as a convenience to the users of this website.
1210576535914242048
#ICYMI results from the Phase 1 study of Gamida Cell’s investigational NK cell immunotherapy were presented at ASH this month. See the details here: https://t.co/zB4fnmrstm